{"id":385558,"date":"2020-11-19T16:08:24","date_gmt":"2020-11-19T21:08:24","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=385558"},"modified":"2020-11-19T16:08:24","modified_gmt":"2020-11-19T21:08:24","slug":"phathom-pharmaceuticals-to-host-virtual-investor-day","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/","title":{"rendered":"Phathom Pharmaceuticals to Host Virtual Investor Day"},"content":{"rendered":"<div class=\"mw_release\">\n<ul type=\"disc\">\n<li>Event to be webcast on Monday, December 14, 2020 at 1:00 PM (ET)<\/li>\n<\/ul>\n<p>FLORHAM PARK, N.J., Nov.  19, 2020  (GLOBE NEWSWIRE) &#8212;  Phathom Pharmaceuticals, Inc.\u00a0(Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today confirmed it will host a virtual Investor Day on December 14, 2020 from 1 pm to 3:30 pm Eastern Time. Members of Phathom\u2019s management team and gastroenterology key opinion leaders will provide updates on the company\u2019s pipeline and commercial strategy.<\/p>\n<p>Those interested in participating are invited to pre-register at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OOhXNn415q90wtQpo0H23tILyxNFaKEhGyiY-UV_2z-XN7jrfIrWSDUariRHWP_1_oneJoVCDafkKkqqVladX3gySZkl7cJuNnZxmoKjdiMs7Lc5nfe_QOKsy6hqIIkd\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/bit.ly\/PHAT-investor-day-2020<\/a>. A replay of the webcast and the slide presentation will be available after the meeting on the News &amp; Events section of the Phathom website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=q5lWGjh0ZbWhxLbZo9N9Xplm3zpVYRhYQlAwaPs1wWT0pTJgdTwyeYt5AcXWAfIP8cIX_m8w3ZRO6wBy55LN6T-WAnekInDs1JGN3ku0GzDf5Or6qUrUUlhzUnX6ZkN0\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/investors.phathompharma.com\/<\/a>.\u00a0\u00a0<\/p>\n<p>\n        <strong>About Phathom<\/strong><br \/>\n        <br \/>Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders. For more information about Phathom, visit the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E_qePis3Fqnkf1cOXHWDK_Mfq-qtf1FXpTSuEu0kOkFUx9LCecXOKDQ6UT8fA3zbIoevxPBiZ3ITeY7LodD9xa0dm6R3Qqv_W7WC_Gur61Q=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.phathompharma.com<\/a> or follow the Company on LinkedIn at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kGALxDH8EC7-gLFyOF2BqPtkKWIA-OjVgRFs4pclwEDOAyoRNK-3kmGPWkZxqgBVAjtBCjAcWlUoGic3AtcFAyrhS0uaIdBC3TAiR6M_HAYOPjnxW2ss6Vxb5sDeU5y1jXGTgZLBGNG2jYS4VPxagw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.linkedin.com\/company\/phathompharma<\/a>.<\/p>\n<p>\n        <strong>CONTACTS<\/strong>\n      <\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Nick Benedetto<br \/>1-877-742-8466<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jVwiYBM5E5kIIKhAlhdy2pOhnwUSJg-_vjlm7dYEeYmv6lwyIPwTOPIOtqVaK9kYiB_tclAaynjVnlyjutg8psmCMLo5neK8gaICcAAKuj0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">media@phathompharma.com<\/a><\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Todd Branning <br \/>1-877-742-8466<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_CfnCmk_hq_yvFkj0kesAgOkQcbx6MAFoGk7FP2KT05LiZ65pLNELE07RbDS0uB120-sg_tZRP0poLb3h-Pkk6IlFD1Hv9vvIGiS_MOh_3w=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ir@phathompharma.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMxNSMzODM1ODY2IzIxODk1NzI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/82cdfbd3-c25f-4716-8c59-7ddc0b65b4b2\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Event to be webcast on Monday, December 14, 2020 at 1:00 PM (ET) FLORHAM PARK, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) &#8212; Phathom Pharmaceuticals, Inc.\u00a0(Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today confirmed it will host a virtual Investor Day on December 14, 2020 from 1 pm to 3:30 pm Eastern Time. Members of Phathom\u2019s management team and gastroenterology key opinion leaders will provide updates on the company\u2019s pipeline and commercial strategy. Those interested in participating are invited to pre-register at http:\/\/bit.ly\/PHAT-investor-day-2020. A replay of the webcast and the slide presentation will be available after the meeting on the News &amp; Events section of the Phathom website at https:\/\/investors.phathompharma.com\/.\u00a0\u00a0 About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Phathom Pharmaceuticals to Host Virtual Investor Day&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-385558","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Phathom Pharmaceuticals to Host Virtual Investor Day - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Phathom Pharmaceuticals to Host Virtual Investor Day - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Event to be webcast on Monday, December 14, 2020 at 1:00 PM (ET) FLORHAM PARK, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) &#8212; Phathom Pharmaceuticals, Inc.\u00a0(Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today confirmed it will host a virtual Investor Day on December 14, 2020 from 1 pm to 3:30 pm Eastern Time. Members of Phathom\u2019s management team and gastroenterology key opinion leaders will provide updates on the company\u2019s pipeline and commercial strategy. Those interested in participating are invited to pre-register at http:\/\/bit.ly\/PHAT-investor-day-2020. A replay of the webcast and the slide presentation will be available after the meeting on the News &amp; Events section of the Phathom website at https:\/\/investors.phathompharma.com\/.\u00a0\u00a0 About &hellip; Continue reading &quot;Phathom Pharmaceuticals to Host Virtual Investor Day&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-19T21:08:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMxNSMzODM1ODY2IzIxODk1NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Phathom Pharmaceuticals to Host Virtual Investor Day\",\"datePublished\":\"2020-11-19T21:08:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/\"},\"wordCount\":227,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4OTMxNSMzODM1ODY2IzIxODk1NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/\",\"name\":\"Phathom Pharmaceuticals to Host Virtual Investor Day - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4OTMxNSMzODM1ODY2IzIxODk1NzI=\",\"datePublished\":\"2020-11-19T21:08:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4OTMxNSMzODM1ODY2IzIxODk1NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4OTMxNSMzODM1ODY2IzIxODk1NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-host-virtual-investor-day\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Phathom Pharmaceuticals to Host Virtual Investor Day\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Phathom Pharmaceuticals to Host Virtual Investor Day - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/","og_locale":"en_US","og_type":"article","og_title":"Phathom Pharmaceuticals to Host Virtual Investor Day - Market Newsdesk","og_description":"Event to be webcast on Monday, December 14, 2020 at 1:00 PM (ET) FLORHAM PARK, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) &#8212; Phathom Pharmaceuticals, Inc.\u00a0(Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today confirmed it will host a virtual Investor Day on December 14, 2020 from 1 pm to 3:30 pm Eastern Time. Members of Phathom\u2019s management team and gastroenterology key opinion leaders will provide updates on the company\u2019s pipeline and commercial strategy. Those interested in participating are invited to pre-register at http:\/\/bit.ly\/PHAT-investor-day-2020. A replay of the webcast and the slide presentation will be available after the meeting on the News &amp; Events section of the Phathom website at https:\/\/investors.phathompharma.com\/.\u00a0\u00a0 About &hellip; Continue reading \"Phathom Pharmaceuticals to Host Virtual Investor Day\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-19T21:08:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMxNSMzODM1ODY2IzIxODk1NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Phathom Pharmaceuticals to Host Virtual Investor Day","datePublished":"2020-11-19T21:08:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/"},"wordCount":227,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMxNSMzODM1ODY2IzIxODk1NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/","name":"Phathom Pharmaceuticals to Host Virtual Investor Day - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMxNSMzODM1ODY2IzIxODk1NzI=","datePublished":"2020-11-19T21:08:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMxNSMzODM1ODY2IzIxODk1NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMxNSMzODM1ODY2IzIxODk1NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-host-virtual-investor-day\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Phathom Pharmaceuticals to Host Virtual Investor Day"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/385558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=385558"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/385558\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=385558"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=385558"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=385558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}